CLINICAL_TRIALS
trial_result
· 2017-05-19
Clinical Trial Update: Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma [Phase 2]
Summary
Phase 2 trial evaluating olaparib in adults with recurrent/metastatic Ewing sarcoma has completed, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Ewing's Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2017-05-19